Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Aroa Biosurgery Ltd ( (AU:ARX) ).
Aroa Biosurgery Limited announced a change in the director’s interest, specifically regarding Brian Ward’s indirect interest in securities. The change involved the lapse of 591,768 options due to vesting conditions not being met, which impacts the director’s holdings but does not involve any acquisition or disposal of new securities. This update reflects the company’s compliance with ASX listing rules and provides transparency to stakeholders about changes in director interests.
The most recent analyst rating on (AU:ARX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on Aroa Biosurgery Ltd stock, see the AU:ARX Stock Forecast page.
More about Aroa Biosurgery Ltd
Aroa Biosurgery Limited operates in the medical technology industry, specializing in the development and manufacturing of regenerative tissue products. The company focuses on providing solutions for complex wound and soft tissue reconstruction, aiming to improve healing outcomes for patients.
Average Trading Volume: 380,334
Technical Sentiment Signal: Sell
Current Market Cap: A$174.2M
Learn more about ARX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue